Skip to main content

Table 1 Characteristics: background, at GH start, after first-year GH treatment

From: Poor growth response during the first year of growth hormone treatment in short prepubertal children with growth hormone deficiency and born small for gestational age: a comparison of different criteria

 

SGA

GHD (all)

Severe GHD (peak GH < 5 μg/L)

Less-severe GHD (peak GH 5–10 μg/L)

n

Mean

SD

Median

p25

p75

n

Mean

SD

Median

p25

p75

n

Mean

SD

Median

p25

p75

n

Mean

SD

Median

p25

p75

Background

 Birth weight, SDS

169

−2.561

0.96

−2.50

− 2.93

− 2.03

121

− 0.441

0.9

− 0.43

− 1.21

0.27

65

− 0.19

0.94

− 0.14

− 0.85

0.47

56

−0.74

0.78

−0.77

−1.35

− 0.13

 Birth length, SDS

163

−2.771

1.02

− 2.65

−3.41

− 2.19

112

−0.591

0.89

−0.58

−1.23

−0.03

61

−0.48

0.87

−0.55

−1.1

0.17

51

−0.71

0.91

− 0.83

−1.4

−0.28

 Sex, % male

64

     

66

     

64

           

 Father height, SDS

164

−1.402

1.12

− 1.48

−2.1

−0.47

118

−0.852

1.27

−0.97

−1.66

− 0.15

64

− 0.72

1.32

−0.67

− 1.65

0.24

54

−0.99

1.2

−1.05

− 1.95

− 0.26

 Mother height, SDS

163

−1.371

1.11

−1.28

−2.12

−0.61

119

−0.771

1.13

−0.78

−1.53

0.07

64

−0.82

1.16

−0.78

−1.55

0.07

55

−0.72

1.11

−0.61

−1.45

0.07

 MPH, SDS

163

−1.391

0.85

−1.42

−1.95

−0.85

118

−0.821

0.92

−0.82

−1.56

−0.27

64

−0.96

1.29

−0.96

−1.99

0.02

54

−1.05

0.98

−0.83

−1.87

−0.4

 Maximum GH peak, μg/L

      

122

4.9

2.6

4.8

3.0

7.1

66

2.9

1.4

3.0

1.9

4.1

56

7.4

1.4

7.3

6.0

8.4

At start GH treatment

 Age, years

171

7.5

2.3

7.5

5.4

9.2

122

6.7

2.9

6.5

4.4

8.8

66

6.5

3.1

5.9

4.2

8.6

56

6.96

2.8

7.7

5.3

8.9

 Height, SDS

171

−3.21

0.65

−3.06

−3.51

−2.77

122

−3.17

0.83

−3.2

−3.69

−2.71

66

−3.33

0.89

−3.32

−3.8

−2.81

56

−2.98

0.7

−2.9

− 3.43

− 2.59

 Weight, SDS

168

−3.341

1.21

−3.29

−4.1

−2.47

120

−2.531

1.19

−2.44

−3.36

−1.69

65

−2.57

1.22

−2.49

−3.34

−1.77

55

−2.48

1.15

−2.4

−3.4

− 1.6

 BMI, SDS

167

−1.281

1.2

−2.21

−2.13

−0.41

113

−0.331

1.13

−0.52

−1.06

0.4

62

−1.17

1.04

−0.46

−0.85

0.63

51

−0.53

1.22

−0.74

−1.18

0.27

 Height SDS minus MPH SDS

163

−1.831

0.87

−1.75

−2.28

−1.21

118

−2.361

1.14

−2.26

−3.04

−1.51

64

−2.58

1.27

−2.41

−3.31

−1.7

54

−2.11

0.9

−2.12

−2.66

−1.42

 GH dose, μg/kg*day

167

38.1

7.2

36.51

33.5

41.2

120

26.2

3,0

25.81

24.4

27.4

65

25.8

3.1

2.3

23.8

27.3

55

26.6

2.9

26,0

24.7

27.4

After first-year GH treatment

 Height, SDS

171

−2.64

0.71

−2.482

−2.98

−2.15

122

−2.35

0.75

−2.322

−2.75

−1.91

66

−2.35

0.78

−2.31

− 2.92

−1.77

56

− 2.35

0.71

− 2.34

−2.69

− 2.05

 ∆ BMI, SDSa

167

0.181

0.47

0.15

−0.15

0.44

120

− 0.211

0.59

− 0.19

− 0.54

0.18

65

− 0.27

0.68

− 0.23

− 0.57

0.2

55

− 0.14

0.47

− 0.14

− 0.48

0.17

 Height SDS minus MPH SDS

163

−1.251

0.91

− 1.15

− 1.78

−0.59

118

− 1.521

0.89

− 1.53

−2.19

− 0.89

64

− 1.58

1.01

−1.61

−2.47

− 0.89

54

− 1.45

0.72

− 1.5

− 1.97

− 0.94

 GH dose during first year, μg/kg*day

167

38.1

6.7

36.41

34,0

41.6

119

26.9

3.2

26.51

25,0

28.2

64

26.6

2.9

26.4

24.9

28.2

55

27.3

3.5

26.5

25,0

28.4

  1. SGA small for gestational age, GHD growth hormone deficiency, GH growth hormone, MPH midparental height, BMI body mass index; a Increase in BMI during first-year GH treatment; 1p < 0,001; 2p < 0,05